QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cdt-equity-announces-1-for-8-reverse-stock-split-effective-october-10-2025

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-f...

 cdt-equity-announces-strategic-purchase-of-865-bitcoin-for-1m-at-an-average-price-of-115285-per-btc

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the strategic acquisition of 8.65252366 B...

 cdt-equity-identifies-new-biological-target-and-therapeutic-use-for-azd1656-through-ai-driven-drug-repurposing

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announces that it has successfully identified a new...

 conduit-pharma-intends-to-change-its-name-to-cdt-equity-inc

Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential...

 conduit-pharmaceuticals-files-new-four-patents-related-to-assets-azd1656-and-azd5658

Includes Conduit's first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION